AMENDMENT AND ASSIGNMENTAmendment and Assignment • June 17th, 2019 • Biohaven Specialty Pharma Ltd. • Pharmaceutical preparations
Contract Type FiledJune 17th, 2019 Company IndustryThis AMENDMENT AND ASSIGNMENT (“Amendment”) dated as of May 29, 2019 among ALS Biopharma, LLC (“ALS”), Fox Chase Chemical Diversity Center (“FCCDC”), and Biohaven Pharmaceutical Holding Company Ltd (“Biohaven”) and Biohaven Therapeutics Ltd. (“Therapeutics”), each designated a “Party” and collectively the “Parties,”)